Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Contributed by: Business Wire

Logo

Tags

Biotechnology

FDA

Health

General Health

Pharmaceutical

Oncology

Neurology

Research

Infectious Diseases

Science

Clinical Trials

H.C. Wainwright 28th Annual Global Investment Conference

More Like This

Prothena to Participate in Upcoming Healthcare Conferences

Prothena to Participate in Upcoming Healthcare Conferences

Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference

Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Prothena to Report First Quarter 2026 Financial Results on May 7

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

Prothena to Report Second Quarter 2026 Financial Results on August 6

Prothena to Report Third Quarter 2023 Financial Results on November 2